The Effect of Diltiazem on Hepatic Drug Oxidation Assessed by Antipyrine and Trimethadione
- 1 December 1991
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 31 (12) , 1132-1136
- https://doi.org/10.1002/j.1552-4604.1991.tb03685.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Dose Dependent Effect of Diltiazem on the Pharmacokinetics of NifedipineThe Journal of Clinical Pharmacology, 1989
- Antipyrine as a model drug to study hepatic drug-metabolizing capacityJournal of Hepatology, 1988
- Inhibition of Theophylline Elimination by Diltiazem TherapyThe Journal of Clinical Pharmacology, 1987
- Simultaneous determination of serum trimethadione and its metabolite by gas chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapyClinical Pharmacology & Therapeutics, 1986
- Diltiazem treatment impairs hepatic drug oxidation: Studies of antipyrineClinical Pharmacology & Therapeutics, 1986
- Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamilBiochemical Pharmacology, 1985
- A method for estimation of hepatic drug-metabolizing capacity: Determination of concentration of trimethadione and its metabolite in human serum.Journal of Pharmacobio-Dynamics, 1984
- Studies of the different metabolic pathways of antipyrine in manEuropean Journal of Clinical Pharmacology, 1982
- Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.Published by Wiley ,1981